Profile data is unavailable for this security.
About the company
Cannabis Global, Inc. manufactures and distributes various cannabis products through its ownership of Natural Plant Extract, Inc. The Company is engaged in developing the Ethos Comply Bag and conducts research and development in the areas of hemp, cannabis, and consumer food goods. It operates and manages Natural Plant Extract of California, Inc. (NPE) which holds two active California cannabis licenses: a Type 7 manufacturing license and a distribution license. These licenses allow NPE to distribute cannabis products in the State of California. These products included several types of cannabis products, including Cannabis flower packaged in various weights, which are sold to California licensed cannabis retailers and distributors; cannabis pre-rolls, which are sold to California licensed cannabis retailers and distributors, and cannabis edible products, which are sold to California licensed cannabis retailers and distributors.
- Revenue in USD (TTM)2.62m
- Net income in USD-3.16m
- Incorporated2020
- Employees3.00
- LocationCannabis Global, Inc.520 S. Grand Avenue, Suite 320LOS ANGELES 90071United StatesUSA
- Phone+1 (310) 986-4929
- Websitehttps://cannabisglobalinc.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Callitas Health Inc | -100.00bn | -100.00bn | 3.26k | -- | -- | -- | -- | -- | -- | -- | -- | -0.0949 | -- | -- | -- | -- | -- | -262.06 | -- | -- | -- | -- | -- | -1,036.99 | 0.0044 | -- | -- | -- | -5.46 | -- | 68.96 | -- | -- | -- |
| Cannabis Global, Inc. | 2.62m | -3.16m | 3.73k | 3.00 | -- | 0.0002 | -- | 0.0014 | -0.0324 | -0.0324 | 0.008 | 0.0058 | 0.1929 | 14.13 | 5.92 | -- | -27.77 | -164.57 | -140.92 | -- | -2.45 | -- | -143.95 | -831.07 | 0.1799 | -1.75 | 0.3238 | -- | 5,829.78 | -- | -58.94 | -- | -- | -- |
| Kaleido Biosciences Inc | 1.10m | -90.29m | 4.26k | 76.00 | -- | 0.0004 | -- | 0.0039 | -2.16 | -2.16 | 0.0264 | 0.249 | 0.0202 | -- | -- | 14,526.32 | -164.94 | -121.82 | -285.99 | -152.67 | -- | -- | -8,178.26 | -16,716.79 | -- | -31.69 | 0.6716 | -- | 13.23 | -- | -10.62 | -- | 42.08 | -- |
